The Leukemia Exploration and Prevention LEAP Grant Program, offered by the American Cancer Society, is designed to accelerate the discovery of cancer interception or prevention therapies specifically targeting RUNX1-FPD hematologic malignancies. This initiative supports independent investigators at any career stage and encourages research that could lead to transformative cancer prevention solutions.
Eligibility Criteria
- Applicants must be independent investigators at any career stage.
- Must be affiliated with a non-profit academic or research institution.
- Open to both U.S. and international researchers.
- Proposed research must be focused on RUNX1-FPD hematologic malignancies and aim at interception or prevention strategies.
Funding Details
Research Scholar Grant (RSG)
- Amount: Up to 215,000 per year
- Duration: Up to 4 years
- Indirect Costs: Additional 10% allowed
Team Grant
- Amount: Up to $430,000 per year
- Duration: Up to 4 years
- Indirect Costs: Additional 10% allowed
Deadline
-
Application Due: December 1, 2025
For additional details or inquiries, applicants are encouraged to contact Paul Campbell, PhD, and submit their application through the Application Portal.